ALHC — Alignment Healthcare Share Price
- $2.19bn
- $2.04bn
- $1.82bn
- 32
- 37
- 91
- 52
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 17.71 | ||
Price to Tang. Book | 26.18 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.98 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -38.05% | ||
Return on Equity | -91.58% | ||
Operating Margin | -5.88% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 756.96 | 959.22 | 1,167.77 | 1,434.16 | 1,823.63 | 2,630.55 | 3,291.8 | 24.59% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Alignment Healthcare, Inc. provides a consumer-centric health care platform that is built to provide seniors with healthcare services. The Company's operations consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. Its consumer brand name, Alignment Health, offers more than 50 Medicare Advantage plans that serve 53 counties across six states. It partners with nationally recognized and local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, Alignment's Virtual Application (AVA). AVA is designed specifically for senior care and provides end-to-end coordination of the healthcare ecosystem. AVA's suite of tools and services is built within a unified data architecture. Medicare Advantage plans are direct-to-consumer and provide a single point of care delivery for hospital insurance benefits, outpatient services and often prescription drug coverage.
Directors
- Joseph Konowiecki NEC (67)
- John Kao CEO (59)
- Thomas Freeman CFO (31)
- Dawn Maroney CEX (53)
- Donald Furman OTH (70)
- Dinesh Kumar OTH (52)
- Jody Bilney IND (59)
- Thomas Carella IND (45)
- David Hodgson IND (64)
- Yon Yoon Jorden IND (66)
- Jacqueline Kosecoff IND
- Jeffrey Margolis IND (58)
- Margaret McCarthy IND (66)
- Mark Mcclellan IND (57)
- Robbert Vorhoff IND (42)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- April 11th, 2014
- Public Since
- March 26th, 2021
- No. of Shareholders
- 68
- No. of Employees
- 1,536
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 191,299,946
- Address
- 1100 W. Town And Country Road, ORANGE, 92868
- Web
- https://www.alignmenthealth.com/
- Phone
- Auditors
- Deloitte & Touche LLP
Upcoming Events for ALHC
Q4 2024 Alignment Healthcare Inc Earnings Release
Similar to ALHC
Acadia Healthcare
NASDAQ Global Select Market
Accolade
NASDAQ Global Select Market
Addus HomeCare
NASDAQ Global Select Market
Amedisys
NASDAQ Global Select Market
Aveanna Healthcare Holdings
NASDAQ Global Select Market
FAQ
As of Today at 19:11 UTC, shares in Alignment Healthcare are trading at $11.45. This share price information is delayed by 15 minutes.
Shares in Alignment Healthcare last closed at $11.45 and the price had moved by +83.2% over the past 365 days. In terms of relative price strength the Alignment Healthcare share price has outperformed the S&P500 Index by +36.34% over the past year.
The overall consensus recommendation for Alignment Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAlignment Healthcare does not currently pay a dividend.
Alignment Healthcare does not currently pay a dividend.
Alignment Healthcare does not currently pay a dividend.
To buy shares in Alignment Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $11.45, shares in Alignment Healthcare had a market capitalisation of $2.19bn.
Here are the trading details for Alignment Healthcare:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: ALHC
Based on an overall assessment of its quality, value and momentum Alignment Healthcare is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Alignment Healthcare is $10.35. That is 9.61% below the last closing price of $11.45.
Analysts covering Alignment Healthcare currently have a consensus Earnings Per Share (EPS) forecast of -$0.67 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alignment Healthcare. Over the past six months, its share price has outperformed the S&P500 Index by +112.06%.
As of the last closing price of $11.45, shares in Alignment Healthcare were trading +49.41% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Alignment Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $11.45.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Alignment Healthcare's management team is headed by:
- Joseph Konowiecki - NEC
- John Kao - CEO
- Thomas Freeman - CFO
- Dawn Maroney - CEX
- Donald Furman - OTH
- Dinesh Kumar - OTH
- Jody Bilney - IND
- Thomas Carella - IND
- David Hodgson - IND
- Yon Yoon Jorden - IND
- Jacqueline Kosecoff - IND
- Jeffrey Margolis - IND
- Margaret McCarthy - IND
- Mark Mcclellan - IND
- Robbert Vorhoff - IND